← Back to Clinical Trials
Recruiting NCT06464471

NCT06464471 Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06464471
Status Recruiting
Phase
Sponsor University of Toronto
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 210 participants
Start Date 2025-03-18
Primary Completion 2026-01-01

Eligibility & Interventions

Sex All sexes
Min Age 70 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Self-reported online geriatric assessment (CHAMP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 210 participants in total. It began in 2025-03-18 with a primary completion date of 2026-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current standard preoperative assessment does not consider the needs of older adults undergoing non-oncological surgery. To enhance the treatment decision-making and planning for older adult surgical patients, the British Geriatric Society and the American Society of Colon and Rectal Surgeons recommend the implementation of preoperative GA for all older adults. Geriatric assessment (GA) predicts treatment toxicity and overall mortality in older adults with complex health problems. However, in-person GA may not be feasible in several clinical settings for various reasons, including lack of training, time, or access to advanced geriatric services. These challenges can be minimized through a self-reported online GA that can be completed by patients prior to the participants' medical appointment. In a previous study, the investigators developed a self-reported online GA, known as the Comprehensive Health Assessment for My Cancer treatment Plan (CHAMP), which was used in geriatric oncology to increase accessibility to GA for older adults with cancer. In this study, the aim is to deploy the CHAMP tool to various clinics across 4 institutions and assess feasibility outcomes, as well as the efficacy of the CHAMP tool in the identification of geriatric issues and the development of supportive care.

Eligibility Criteria

Inclusion Criteria: * Patients aged 70 years old and over who have been referred to any kind of non-oncological surgery * Able to speak English * Able to provide informed consent Exclusion Criteria: \-

Contact & Investigator

Central Contact

Martine Puts, PhD RN

✉ martine.puts@utoronto.ca

📞 416-978-6059

Principal Investigator

Martine Puts, PhD RN

PRINCIPAL INVESTIGATOR

University of Toronto

Frequently Asked Questions

Who can join the NCT06464471 clinical trial?

This trial is open to participants of all sexes, aged 70 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06464471 currently recruiting?

Yes, NCT06464471 is actively recruiting participants. Contact the research team at martine.puts@utoronto.ca for enrollment information.

Where is the NCT06464471 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT06464471 clinical trial?

NCT06464471 is sponsored by University of Toronto. The principal investigator is Martine Puts, PhD RN at University of Toronto. The trial plans to enroll 210 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology